Sino Biological,Inc. (SHE:301047)
159.00
+15.74 (10.99%)
At close: Sep 30, 2026
Sino Biological,Inc. Market Cap
Sino Biological,Inc. has a market cap or net worth of 19.34 billion as of October 2, 2026. Its market cap has increased by 114.49% in one year.
Market Cap
19.34B
Enterprise Value
16.25B
Revenue
768.00M
Ranking
n/a
PE Ratio
117.04
Stock Price
159.00
ChartMarket Cap Chart
Since August 16, 2021, Sino Biological,Inc.'s market cap has decreased from 33.55B to 19.34B, a decrease of -42.35%. That is a compound annual growth rate of -10.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 19.34B | 135.21% |
| Dec 31, 2025 | 8.22B | 9.30% |
| Dec 31, 2024 | 7.52B | -29.33% |
| Dec 29, 2023 | 10.65B | -17.32% |
| Dec 30, 2022 | 12.88B | -45.23% |
| Dec 31, 2021 | 23.51B | -29.92% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 20.56B |
| Xiamen Amoytop Biotech | 20.35B |
| Hebei Changshan Biochemical Pharmaceutical | 20.33B |
| Evopoint Biosciences | 18.99B |
| Yili Chuanning Biotechnology | 17.95B |
| HitGen | 17.50B |
| Sinocelltech Group | 16.57B |
| BrightGene Bio-Medical Technology | 14.95B |